about
Drug-loaded erythrocytes: on the road toward marketing approvalInternational seminar on the red blood cells as vehicles for drugs.Poor Outcome in a Mitochondrial Neurogastrointestinal Encephalomyopathy Patient with a Novel TYMP Mutation: The Need for Early Diagnosis.The development and validation of an immunoassay for the measurement of anti-thymidine phosphorylase antibodies in mouse and dog sera.Energy metabolism and glycolysis in human placental trophoblast cells during differentiation.Validation of a HPLC method for the measurement of erythrocyte encapsulated thymidine phosphorylase (EE-TP) activity.In vitro studies of amikacin-loaded human carrier erythrocytes.Blood viscosity and its relationship to iron deficiency, symptoms, and exercise capacity in adults with cyanotic congenital heart disease.Seeking optimal relation between oxygen saturation and hemoglobin concentration in adults with cyanosis from congenital heart disease.A 9-yr evaluation of carrier erythrocyte encapsulated adenosine deaminase (ADA) therapy in a patient with adult-type ADA deficiency.The mouse immune response to carrier erythrocyte entrapped antigens.A novel hysteroscopic technique for the accurate biopsy of decidua parietalis and basalis.Dimensional analysis of osteoclastic bone resorption and the measurement of biologically active calcitoninValidation of an Immunoassay for Anti-thymidine Phosphorylase Antibodies in Patients with MNGIE Treated with Enzyme Replacement TherapyMitochondrial Neurogastrointestinal Encephalomyopathy: Into the Fourth Decade, What We Have Learned So FarOrgans to Cells and Cells to Organoids: The Evolution of Central Nervous System ModellingSafety and Efficacy of Erythrocyte Encapsulated Thymidine Phosphorylase in Mitochondrial Neurogastrointestinal EncephalomyopathyIn vitro and in vivo studies with human carrier erythrocytes loaded with polyethylene glycol-conjugated and native adenosine deaminaseCarrier erythrocyte entrapped adenosine deaminase therapy in adenosine deaminase deficiencyBone morphogenetic protein-2 increases the rate of callus formation after fracture of the rabbit tibiaSurvival of human carrier erythrocytes in vivoPulmonary arterial thrombosis in eisenmenger syndrome is associated with biventricular dysfunction and decreased pulmonary flow velocityPreclinical toxicity evaluation of erythrocyte-encapsulated thymidine phosphorylase in BALB/c mice and beagle dogs: an enzyme-replacement therapy for mitochondrial neurogastrointestinal encephalomyopathyUnexplained gastrointestinal symptoms: think mitochondrial diseaseQuantification of Plasma and Urine Thymidine and 2'-Deoxyuridine by LC-MS/MS for the Pharmacodynamic Evaluation of Erythrocyte Encapsulated Thymidine Phosphorylase in Patients with Mitochondrial Neurogastrointestinal EncephalomyopathyDiscovery profiling and bioinformatics analysis of serum microRNA in Mitochondrial NeuroGastroIntestinal Encephalomyopathy (MNGIE)The development of an in vitro cerebral organoid model for investigating the pathomolecular mechanisms associated with the central nervous system involvement in Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE)Erythrocyte Encapsulated Thymidine Phosphorylase for the Treatment of Patients with Mitochondrial Neurogastrointestinal Encephalomyopathy: Study Protocol for a Multi-Centre, Multiple Dose, Open Label TrialErythrocytes as Carriers of Therapeutic Enzymes
P50
Q26765322-3CD7E036-C823-4655-BC01-F2A4533B7408Q36382149-F8EE27C7-92D2-419A-B416-75DFCBA60B22Q39480761-4A72900E-DF13-4B19-AF03-A6C651D28733Q39521279-84048249-BC7B-4DCB-95DB-A96CF528FFF5Q42437734-9637883B-3594-4B56-8A30-A5547B8E230AQ43431056-E664CFFE-C4D7-4175-8FCA-85859BB72C45Q46449830-C59C16AF-3A2D-4D09-BD63-46EA59F3865AQ50728446-55CA169B-BE31-4987-9B46-DFB10E7F005EQ51606417-BF6C95F2-6EEF-430C-B076-0F7763533B11Q51979076-8A98779C-FA8A-4B74-8234-1DCC3F60F75DQ52015425-8E5EDA6B-B51D-44BC-BD3F-AE23A6EC5BA2Q53180135-8935CE5E-6A66-498D-8534-2CC5453DD51EQ57103517-FA7CA9A3-8B94-4977-A60B-9CCCCBCAFD0EQ57192798-71AFE662-30E8-4E23-9011-D5F4E0959808Q60938307-65B4EFC9-E6DB-4DC9-863B-F49E14B79DA6Q63740160-EABB1D78-89E8-407F-8619-4A20E95548C7Q64039585-02D2034C-7104-4817-8E2B-A3550B655EC4Q73968435-41E7B86C-6DCE-4903-A89C-B84A109DF9A1Q77468296-AE46B25A-D16C-43B8-AD6F-27750C80B301Q77884641-C9CF5DA5-F7B7-4DF6-B860-6549CDE0F207Q77906126-ADE398CA-7FDF-4A45-8104-7D99646ABCD9Q80783542-48F47171-D6D4-44E3-A398-8E2FDFF264D8Q84972236-8D89124B-85AB-4E6D-8DDC-3C507711D216Q86954219-C262CF63-2451-4744-8DB9-08CE6F6C18B4Q90398021-6CF3E4F9-9B32-437F-8E3E-50344DD8195CQ90761694-1FD3CCBF-C65B-4CE5-822F-0BB45F9CD320Q90761724-12EEE518-BA20-47CD-82DA-7F113802FC15Q92178673-1CD58B23-67EC-48AB-B0EB-7062226C5CF3Q94590600-B723F001-B430-49F9-9BE3-2E478F937FAA
P50
description
researcher
@en
wetenschapper
@nl
name
Bax BE
@nl
Bridget E. Bax
@en
type
label
Bax BE
@nl
Bridget E. Bax
@en
altLabel
Bax BE
@en
prefLabel
Bax BE
@nl
Bridget E. Bax
@en
P106
P31
P496
0000-0001-6306-080X